Pai Rekha B, Pai S Balakrishna, Yang Lily, Joshi Harish C
Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322.
Oncol Lett. 2010 Mar;1(2):339-343. doi: 10.3892/ol_00000060. Epub 2010 Mar 1.
Breast tumors are the second major cause of cancer-related death in women worldwide. These tumors are aggressive, leading to metastatic cancers that are heterogeneous in nature, with numerous subtypes. The basal-like tumor subtype invariably shows unfavorable prognosis and is often characterized by the lack of estrogen, progesterone and HER2 receptors. These cancer types do not respond to the current targeted therapies. Therefore, the need for the discovery of novel diagnostic markers/therapeutic targets is of paramount importance. Immortalization of breast tumor cells leading to advanced stage cancer is one of the pivotal steps in breast cancer and telomeres/telomerase play a critical role in this process. Using single telomere length analysis, cell lines with a basal-like phenotype encompassing immortalized/non-tumorigenic MCF10A and invasive/metastatic MCF10CA1 along with the MCF-7 cell line were examined for the presence of a unique class of telomere t-stumps. Telomerase activity, protein levels of telomerase and bulk telomere lengths were assessed in the above-mentioned cell lines. This is the first study describing the existence of a distinct class of extremely short telomeres termed 't-stumps' in breast cancer cell lines. The cell lines MCF10A and MCF10CA1 showed distinct telomeric bands in the molecular size range of 100-1,000 bp, whereas the MCF-7 cell line showed very low levels of t-stumps. Of note is that only the highly invasive/metastatic cancer cell line MCF10CA1 exhibited an abundance of a cluster of t-stumps with a size distribution range of 500-700 bp. These unique t-stumps observed in the advanced breast cancer cell line may serve as a novel diagnostic marker and also form a key molecular target for novel anticancer therapy.
乳腺癌是全球女性癌症相关死亡的第二大主要原因。这些肿瘤具有侵袭性,会导致本质上异质性的转移性癌症,有众多亚型。基底样肿瘤亚型总是显示出不良预后,其特征通常是缺乏雌激素、孕激素和HER2受体。这些癌症类型对当前的靶向治疗无反应。因此,发现新型诊断标志物/治疗靶点至关重要。乳腺肿瘤细胞永生化导致癌症进展是乳腺癌的关键步骤之一,端粒/端粒酶在此过程中起关键作用。使用单端粒长度分析,对具有基底样表型的细胞系进行检测,这些细胞系包括永生化/非致瘤性的MCF10A和侵袭性/转移性的MCF10CA1以及MCF-7细胞系,以检查是否存在一类独特的端粒t-残端。在上述细胞系中评估了端粒酶活性、端粒酶蛋白水平和总体端粒长度。这是第一项描述在乳腺癌细胞系中存在一类独特的极短端粒(称为“t-残端”)的研究。MCF10A和MCF10CA1细胞系在100 - 1000 bp的分子大小范围内显示出独特的端粒条带,而MCF-7细胞系显示出极低水平的t-残端。值得注意的是,只有高侵袭性/转移性癌细胞系MCF10CA1表现出大量大小分布在500 - 700 bp的t-残端簇。在晚期乳腺癌细胞系中观察到的这些独特的t-残端可能作为一种新型诊断标志物,也构成新型抗癌治疗的关键分子靶点。